SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (1036)10/5/2000 3:50:41 PM
From: Ian@SI  Read Replies (1) | Respond to of 1321
 
I'll wait until I see the show tonight before jumping to that conclusion.

I shipped off another email requesting that the Strong Buys be mentioned if they choose to mention LeDink's report.

I'll either post an apology to CBC tonight or another blister. The choice is theirs! :-)

Ian.



To: Edward W. Richmond who wrote (1036)10/11/2000 1:33:27 PM
From: Julian  Read Replies (1) | Respond to of 1321
 
QLT Inc. Reiterated `Strong Buy' at Deutsche Banc AB
By Sybil Carlson
Princeton, New Jersey, Oct. 11 (Bloomberg Data) -- QLT Inc. (QLTI US) was reiterated ``strong buy'' by analyst Kevin C. Tang at Deutsche Banc Alex. Brown. The 12-month target price is US$102.00 per share.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News